Stealth Biotherapeutics Corp lands $20m
Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement.
Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement.
Copyright PEI Media
Not for publication, email or dissemination
